Supplemental data for the manuscript: Efficacy and safety of weekly somatrogon vs daily somatropin in children with growth hormone deficiency: a phase 3 study

Supplemental Methods – This is a description of the additional inclusion and exclusion criteria and the adverse events of special interest.

Supplemental Table S1 – This dataset describes the incidence and severity of all-causality treatment-emergent adverse events.

Supplemental Table S2 – This dataset describes the treatment-related adverse events stratified according to whether subjects had two consecutive increases in IGF-1 SDS >2

Supplemental Table S3 – This dataset shows the values for glucose metabolism for subjects throughout the study.

Supplemental Figure S1 – This dataset shows the height velocities for all the individual subjects.

Supplemental Figure S2 – This dataset shows the instances of injection site pain for subjects throughout the study.